Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN)
Chinese Academy of Medical Sciences & Peking Union Medical College · Hangzhou Center for Disease Control and Prevention · +2 more institutions
Abstract
The International Agency for Research on Cancer (IARC) released the latest estimates of the global burden of cancer. We present a comparison of cancer profiles between 2020 and 2022, leveraging data from the Global Cancer Statistics (GLOBOCAN).
Cancer incidence and mortality data were sourced from two different years, 2020 and 2022, in the GLOBOCAN database. We tracked changes in age-standardized incidence and mortality rates, as well as estimated numbers of new cancer cases and deaths of the 15 most common cancer types globally and in China between 2020 and 2022. Additionally, we conducted comparisons to assess alterations in the cancer burden and variations in mortality-to-incidence ratio (MIR) across different regions and countries for both 2020 and 2022.
Citation impact
- FWCI
- 62.49
- Percentile
- 100%
- References
- 23
Authors
4- WCWei Cao
Chinese Academy of Medical Sciences & Peking Union Medical College
- KQKang Qin
Hangzhou Center for Disease Control and Prevention
- FLFeng Li
Third People's Hospital of Hangzhou, The First People's Hospital of Xiaoshan District, Hangzhou
- WCWanqing ChenCorresponding
Chinese Academy of Medical Sciences & Peking Union Medical College
Topics & keywords
- Statistics
- Cancer
- Mathematics
- Econometrics
- Biology
- Genetics